Journal of Natural Products
Article
(10 μg/sample). The mixture was filtered to give a crude extract, and
the volatile components of the extract were removed under reduced
pressure to give a residue, which was mixed with a solution of EtOAc
(10 mL). The mixture was successively washed with 0.5 M HCl (10
mL) and saturated aqueous NaHCO3 (10 mL), and the organic layer
was dried over Na2SO4. The volatile components of the organic layer
were removed under reduced pressure to give a residue, which was
mixed with a solution of EtOAc−n-hexane (3:2, 1 mL). The mixture
was loaded on a silica gel column, which was eluted into sample tubes
(20 mL each) using a solution of EtOAc−n-hexane (3:2, 100 mL).
The eluates in the second to fourth fractions were mixed, and their
volatile components were removed in vacuo to give a residue. The
residue was dissolved in a mixture of MeOH−H2O (4:1, 100 μL), and
a portion of the solution (5 μL) was subjected to UPLC MS/MS.
Synthesis of Compound 5. The synthesis of 5 was conducted
according to a previously reported method,19 with the exception that
6-bromohexan-1-ol was used as a starting material.
7.9 Hz), 3.96 (1H, d, J = 2.8 Hz), 3.91−3.74 (2H, m), 3.58 (1H, s),
3.41 (3H, s), 2.86 (4H, d, J = 15.8 Hz), 2.13−1.95 (6H, m), 1.49 (2H,
d, J = 6.6 Hz), 1.45−1.07 (23H, m), 0.91 (5H, t, J = 7.4 Hz); UPLC-
Tof MS m/z 591.2933 [M + Na]+ (calcd for C31H43O6F3Na,
591.2909).
MTPA ester of 3a: 1H NMR (500 MHz, benzene-d6) δ 7.68 (2H, d,
J = 7.6 Hz), 7.13−6.96 (3H, m), 5.57−5.34 (6H, m), 4.06 (1H, dd, J =
11.3, 6.6 Hz), 3.96 (1H, dd, J = 11.3, 4.1 Hz), 3.82 (ddd, J = 28.6, 11.7,
4.8 Hz), 3.57 (1H, d, J = 4.7 Hz), 3.41 (3H, s), 2.95−2.77 (4H, m),
2.14−1.93 (6H, m), 1.66 (1H, d, J = 3.8 Hz), 1.50 (2H, t, J = 6.8 Hz),
1.41−1.05 (9H, m), 0.91 (3H, t, J = 7.6 Hz); UPLC-Tof MS m/z
591.2896 [M + Na]+ (calcd for C31H43O6F3Na, 591.2909).
MTPA ester of 3b: 1H NMR (500 MHz, benzene-d6) δ 7.68 (2H, d,
J = 7.6 Hz), 7.13−6.96 (3H, m), 5.55−5.36 (6H, m), 4.05 (1H, dd, J =
11.0, 3.5 Hz), 3.97 (1H, dd, J = 11.5, 5.5 Hz), 3.92−3.77 (2H, m), 3.59
(1H, s), 3.41 (3H, s), 2.95−2.78 (4H, m), 2.10−1.97 (6H, m), 1.65
(1H, s), 1.50 (2H, t, J = 6.8 Hz), 1.44−1.06 (17H, m), 0.91 (3H, t, J =
7.4 Hz); UPLC-Tof MS m/z 591.2890 [M + Na]+ (calcd for
C31H43O6F3Na, 591.2909).
(7Z,10Z,13Z)-Hexadecatrienoic acid (5): 1H NMR (270 MHz,
CDCl3) δ 5.35 (6H, m), 2.78 (4H, t, J = 5.4 Hz), 2.33 (2H, t, J = 8.1
Hz), 2.05 (5H, m), 1.63 (3H, m), 1.50−1.20 (8H, m), 0.96 (3H, t, J =
8.1 Hz); FDMS m/z 250 [M]+ (100).
Synthesis of Deuterium-Labeled Compounds 8 and 9.
Compounds 5 (24.3 mg, 0.1 mmol) and α-linolenic acid (26.0 mg,
0.1 mmol) were prepared. A fatty acid in CH2Cl2 (5 mL) was added to
a stirred mixture of N,N′-dicyclohexylcarbodiimide (DCC, 34.0 mg,
0.17 mmol), N,N-dimethyl-4-aminopyridine (DMAP, 3.7 mg, 0.03
mmol), and glycerol-1,1,2,3,3-d5 (28.3 mg, Sigma-Aldrich, St. Louis,
MO, USA), and the reaction mixture was further stirred at room
temperature for 24 h. The usual workup was employed to give a crude
material, which was purified using silica gel column chromatography
with EtOAc−n-hexane (3:2) and HPLC [YMC Pack ODS-AM, f 10 ×
300 mm, 2 mL/min, 210 nm, MeOH−H2O (9:1)] to afford
compounds 8 (4.2 mg, 0.013 mmol) and 9 (8.0 mg, 0.022 mmol).
[2H2-1,2H1-2,2H2-3]-α-(7′Z,10′Z,13′Z)-Hexadecatrienoic acid
monoglyceride (8): HRFDMS m/z 329.26269 (calcd for
C19H27D5O4, 329.26144).
General Procedure for the Synthesis of Compounds 1a, 1b,
3a, and 3b. They were synthesized according to a reported method.20
(2S)-α-(7′Z,10′Z,13′Z)-Hexadecatrienoic acid monoglyceride
(1a): [α]26 +4.4 (c 0.75, MeOH); HRFDMS m/z 324.23118 (calcd
D
for C19H32O4, 324.23006).
(2R)-α-(7′Z,10′Z,13′Z)-Hexadecatrienoic acid monoglyceride
(1b): [α]26 −4.5 (c 0.75, MeOH); FDMS m/z 324 [M]+ (100),
D
325 [M + H]+ (30.6); HRFDMS m/z 324.23175 (calcd for C19H32O4,
324.23006).
(2S)-α-(9′Z,12′Z,15′Z)-Octadecatrienoic acid monoglyceride
(3a): [α]27 +3.8 (c 0.42, MeOH); HRFDMS m/z 352.26028 (calcd
D
for C21H36O4, 352.26136).
(2R)-α-(9′Z,12′Z,15′Z)-Octadecatrienoic acid monoglyceride
(3b): [α]27 −3.9 (c 0.19, MeOH); HRFDMS m/z 352.26039
[2H2-1,2H1-2,2H2-3]-α-(9′Z,12′Z,15′Z)-Octadecatrienoic acid
monoglyceride (9): HRFDMS m/z 357.29315 (calcd for
C21H31D5O4, 357.29274).
D
(calcd for C21H36O4, 352.26136).
General Procedure of MTPA Esterification. A solution of (S)-
MTPACl (10 mg, 0.04 mmol) in dry pyridine (0.4 mL) was added to
1 (7.0 mg) in a two-necked flask, and the reaction mixture was stirred
at room temperature for 16 h. The reaction mixture was washed with 1
M HCl (30 mL), saturated aqueous NaHCO3 (30 mL), and brine (30
mL), and the organic layer was dried over Na2SO4. The volatile
components of the organic layer were removed under reduced
pressure to give a residue. The residue was purified by silica gel
column chromatography with EtOAc−n-hexane (1:3) to afford the
corresponding product.
Root Growth Inhibition Assay. The root growth inhibitory test
was performed according to a reported method.21
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
■
S
MTPA ester of 1: 1H NMR (500 MHz, benzene-d6) δ 7.68 (2H, d, J
= 7.9 Hz), 7.14−6.97 (3H, m), 5.55−5.32 (6H, m), 4.13−4.02 (1H,
m), 4.02−3.93 (1H, m), 3.92−3.75 (2H, m), 3.59 (1H, d, J = 4.4 Hz),
3.41 (3H, s), 2.85 (4H, t, J = 5.4 Hz), 2.10−1.92 (6H, m), 1.69 (1H,
s), 1.57−1.43 (2H, m), 1.43−1.11 (12H, m), 0.92 (5H, t, J = 7.6 Hz);
UPLC-Tof MS m/z 563.2570 [M + Na]+ (calcd for C29H39O6F3Na,
563.2569).
Representative HPLC features for purification and
representative UPLC MS/MS features for compounds
1−4; FDMS, 1H NMR, 13C NMR, DEPT, COSY,
1
HSQC, and HMBC spectra for 2; H NMR spectra for
each (S)-MTPA ester; synthetic Schemes S1−S3 for 1b,
3a, 3b; and conditions of MS optimization for multiple
reaction monitoring in the positive mode for compounds
1
MTPA ester of 1a: H NMR (500 MHz, benzene-d6) δ 7.67 (2H,
d), 7.24−6.94 (3H, m), 5.55−5.31 (6H, m), 4.07 (1H, dd, J = 11.3, 6.6
Hz), 3.96 (1H, dd, J = 11.3, 4.1 Hz), 3.85 (1H, dd, J = 11.7, 4.4 Hz),
3.79 (1H, dd, J = 11.8, 5.8 Hz), 3.59 (1H, d, J = 5.0 Hz), 3.41 (3H, s),
2.85 (4H, t, J = 5.4 Hz), 2.07−1.95 (6H, m), 1.72 (1H, d, J = 4.7 Hz),
1.57−1.40 (2H, m), 1.38−1.10 (5H, m), 0.91 (3H, t, J = 7.6 Hz);
UPLC-Tof MS m/z 563.2649 [M + Na]+ (calcd for C29H39O6F3Na,
563.2569).
AUTHOR INFORMATION
Corresponding Author
*Tel: + 81 11 706 2495. Fax: + 81 11 706 2505. E-mail:
■
MTPA ester of 1b: 1H NMR (500 MHz, benzene-d6) δ 7.68 (2H, d,
J = 7.6 Hz), 7.07 (3H, dt, J = 31.3, 7.4 Hz), 5.51−5.36 (6H, m), 4.13−
4.03 (1H, m), 4.02−3.94 (1H, m), 3.91−3.77 (2H, m), 3.60 (1H, s),
3.41 (3H, s), 2.85 (4H, t, J = 5.4 Hz), 2.08−1.96 (6H, m), 1.69 (1H,
s), 1.54−1.43 (2H, m), 1.41−1.11 (10H, m), 0.92 (3H, t, J = 7.6 Hz);
UPLC-Tof MS m/z 563.2645 [M + Na]+ (calcd for C29H39O6F3Na,
563.2569).
ORCID
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
The authors would like to thank Mr. Y. Takata and Dr. E.
Fukushi (Faculty of Agriculture, Hokkaido University) for
■
MTPA ester of 3: 1H NMR (500 MHz, benzene-d6) δ 7.67 (2H, d, J
= 7.3 Hz), 7.12−6.95 (3H, m), 5.55−5.36 (6H, m), 4.05 (1H, d, J =
F
J. Nat. Prod. XXXX, XXX, XXX−XXX